Cell Impact AB (publ) (STO:CI)

Paycor HCM Statistics

Total Valuation

Cell Impact AB has a market cap or net worth of SEK 17.72 million. The enterprise value is 39.69 million.

Market Cap	17.72M
Enterprise Value	39.69M

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Cell Impact AB has 984.27 million shares outstanding. The number of shares has increased by 170.13% in one year.

Current Share Class	984.27M
Shares Outstanding	984.27M
Shares Change (YoY)	+170.13%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.38%
Owned by Institutions (%)	13.62%
Float	921.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.09
P/TBV Ratio	0.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.40
EV / Sales	1.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.93

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.14.

Current Ratio	2.15
Quick Ratio	0.60
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-0.65
Interest Coverage	-37.77

Financial Efficiency

Return on equity (ROE) is -41.28% and return on invested capital (ROIC) is -22.25%.

Return on Equity (ROE)	-41.28%
Return on Assets (ROA)	-20.91%
Return on Invested Capital (ROIC)	-22.25%
Return on Capital Employed (ROCE)	-46.03%
Revenue Per Employee	845,300
Profits Per Employee	-2.46M
Employee Count	41
Asset Turnover	0.12
Inventory Turnover	0.61

Taxes

Income Tax	-575,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.42% in the last 52 weeks. The beta is 1.45, so Cell Impact AB's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	-94.42%
50-Day Moving Average	0.03
200-Day Moving Average	0.11
Relative Strength Index (RSI)	35.33
Average Volume (20 Days)	13,077,399

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cell Impact AB had revenue of SEK 33.81 million and -98.53 million in losses. Loss per share was -0.15.

Revenue	33.81M
Gross Profit	1.37M
Operating Income	-97.76M
Pretax Income	-99.11M
Net Income	-98.53M
EBITDA	-78.62M
EBIT	-97.76M
Loss Per Share	-0.15

Balance Sheet

The company has 5.83 million in cash and 27.80 million in debt, giving a net cash position of -21.97 million or -0.02 per share.

Cash & Cash Equivalents	5.83M
Total Debt	27.80M
Net Cash	-21.97M
Net Cash Per Share	-0.02
Equity (Book Value)	197.55M
Book Value Per Share	0.28
Working Capital	30.51M

Cash Flow

In the last 12 months, operating cash flow was -36.32 million and capital expenditures -6.17 million, giving a free cash flow of -42.50 million.

Operating Cash Flow	-36.32M
Capital Expenditures	-6.17M
Free Cash Flow	-42.50M
FCF Per Share	-0.04

Margins

Gross margin is 4.04%, with operating and profit margins of -289.12% and -291.41%.

Gross Margin	4.04%
Operating Margin	-289.12%
Pretax Margin	-293.11%
Profit Margin	-291.41%
EBITDA Margin	-232.51%
EBIT Margin	-289.12%
FCF Margin	n/a

Dividends & Yields

Cell Impact AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-170.13%
Shareholder Yield	n/a
Earnings Yield	-556.15%
FCF Yield	-239.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cell Impact AB has an Altman Z-Score of -2.86 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.86
Piotroski F-Score	3